| Developers: | Philips Healthcare |
| Date of the premiere of the system: | May, 2019 |
| Branches: | Pharmaceutics, medicine, health care |
2019: Announcement
In the middle of May, 2019 Philips Healthcare submitted the platform for intervention applications of IntraSight. She offers the set of applications for carrying out intravaskulyarny interventions and procedures under ultrasonography control, accelerating routine researches.
Philips IntraSight gives to doctors an opportunity to create ultrasonographs of blood vessels of internals (intra vascular ultrasonography) and to execute measurements of arterial blood pressure thanks to assessment of a fractional reserve of blood circulation and an instant indicator of a free wave (iFR) - the index developed by Philips company for assessment of coronary vessels. There are more and more clinical data that use of such technologies in combination with intervention therapy improves results of treatment of patients.
The platform of intervention applications IntraSight offers the intuitive interface with the touch screen for data management, system integration and diagnostics within remote maintenance. The combination of IntraSight and Azurion, the Philips platform for therapy with visual control, allows doctors to obtain necessary information in full in time. The modern intuitive interface IntraSight minimizes learning curves and increases reliability of workflow.
The Philips SyncVision application is improved by care of patients, displaying on the angiogram both a pressure profile, and OUSE measurement of all vessel. Thanks to opportunities of a new system doctors can identify more precisely ischemia sections, plan length and placement of the stent using virtual modeling and to estimate the forecast of the patient.
IntraSight, SyncVision and iFR are a part of a unique portfolio of Philips in the field of medical visualization.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |